Flavonoids and Polyphenolic Compounds as Potential Talented Agents for the Treatment of Alzheimer's Disease and their Antioxidant Activities

被引:19
作者
Akter, Rokeya [1 ,3 ]
Chowdhury, Md Arifur Rahman [1 ,3 ]
Rahman, Md Habibur [2 ]
机构
[1] Jagannath Univ, Dept Pharm, Dhaka 1100, Bangladesh
[2] Southeast Univ, Dept Pharm, Dhaka 1213, South Korea
[3] Jeonbuk Natl Univ, Dept Bioact Mat Sci, Jeonju, South Korea
关键词
Alzheimer's disease; flavonoids; amyloid-beta; antioxidant; neuroprotection; tau protein; reactive oxygen species; MILD COGNITIVE IMPAIRMENT; MONOAMINE-OXIDASE-B; OXIDATIVE STRESS; PARKINSONS-DISEASE; MOUSE MODEL; INTESTINAL-ABSORPTION; INDUCED APOPTOSIS; DRUG DISCOVERY; IN-VITRO; RESVERATROL;
D O I
10.2174/1381612826666201102102810
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Aging is a normal human cycle and the most important risk factor for neurodegenerative diseases. Alternations in cells due to aging contribute to loss of the nutrient-sensing, cell function, increased oxidative stress, loss of the homeostasis cell, genomic instability, the build-up of malfunctioning proteins, weakened cellular defenses, and a telomere split. Disturbance of these essential cellular processes in neuronal cells can lead to life threats including Alzheimer's disease (AD), Huntington's disease (HD), Lewy's disease, etc. The most common cause of death in the elderly population is AD. Specific therapeutic molecules were created to alleviate AD's social, economic, and health burden. In clinical practice, almost every chemical compound was found to relieve symptoms only in palliative treatment. The reason behind these perfect medicines is that the current medicines are not effective in targeting the cause of this disease. In this paper, we explored the potential role of flavonoid and polyphenolic compounds, which could be the most effective preventative anti-Alzheimer 's strategy.
引用
收藏
页码:345 / 356
页数:12
相关论文
共 126 条
  • [1] The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
    Albert, Marilyn S.
    DeKosky, Steven T.
    Dickson, Dennis
    Dubois, Bruno
    Feldman, Howard H.
    Fox, Nick C.
    Gamst, Anthony
    Holtzman, David M.
    Jagust, William J.
    Petersen, Ronald C.
    Snyder, Peter J.
    Carrillo, Maria C.
    Thies, Bill
    Phelps, Creighton H.
    [J]. ALZHEIMERS & DEMENTIA, 2011, 7 (03) : 270 - 279
  • [2] Pharmacokinetic and safety profile of trans-resveratrol in a rising multiple-dose study in healthy volunteers
    Almeida, Luis
    Vaz-da-Silva, Manuel
    Falcao, Amilcar
    Soares, Eva
    Costa, Raquel
    Loureiro, Ana I.
    Fernandes-Lopes, Carlos
    Rocha, Jose-Francisco
    Nunes, Teresa
    Wright, Lyndon
    Soares-da-Silva, Patricio
    [J]. MOLECULAR NUTRITION & FOOD RESEARCH, 2009, 53 : S7 - S15
  • [3] Can herbs provide a new generation of drugs for treating Alzheimer's disease?
    Anekonda, TS
    Reddy, PH
    [J]. BRAIN RESEARCH REVIEWS, 2005, 50 (02) : 361 - 376
  • [4] [Anonymous], 2010, ALTERN MED REV, V15, P152
  • [5] Anonymous, 1998, Alt. Med. Rev, V3, P140
  • [6] Protective effect of quercetin in primary neurons against Aβ(1-42): relevance to Alzheimer's disease
    Ansari, Mubeen Ahmad
    Abdul, Hafiz Mohammad
    Joshi, Gururaj
    Opii, Wycliffe O.
    Butterfield, D. Allan
    [J]. JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2009, 20 (04) : 269 - 275
  • [7] Neuroprotective Effect of Cardamom Oil Against Aluminum Induced Neurotoxicity in Rats
    Auti, Sandip T.
    Kulkarni, Yogesh A.
    [J]. FRONTIERS IN NEUROLOGY, 2019, 10
  • [8] Badalzadeh R, 2015, ADV PHARM BULL, V5, P321, DOI 10.15171/apb.2015.045
  • [9] Bagli E, 2016, IN VIVO, V30, P535
  • [10] Bhadbhade A., 2012, IRAN J CHILD NEUROL, V34, P185